San Diego, United Kingdom

Julian Down

This inventor holds 1 USPTO granted patent. Top assignee: Poseida Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julian Down. Retrieved from https://idiyas.com/inventor/julian-down-s11ykck2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Julian Down

Introduction

Julian Down is a notable inventor based in San Diego, GB. He has made significant contributions to the field of metabolic liver disorders through his innovative work. His dedication to research and development has led to advancements that can potentially improve patient outcomes.

Latest Patents

Julian Down holds a patent titled "Compositions and Methods for the Treatment of Metabolic Liver Disorders." This patent represents his commitment to addressing critical health issues and showcases his expertise in the field.

Career Highlights

Julian Down is currently associated with Poseida Therapeutics, Inc., where he continues to work on groundbreaking research. His role at the company allows him to collaborate with other talented professionals in the industry.

Collaborations

Some of his notable coworkers include Eric Michael Ostertag and Jingjing Jiang. Their combined efforts contribute to the innovative environment at Poseida Therapeutics, Inc.

Conclusion

Julian Down's work exemplifies the spirit of innovation in the medical field. His contributions to the treatment of metabolic liver disorders highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…